Results 111 to 120 of about 183,501 (239)

Cannabidiol Use in Inflammatory Bowel Disease: Insights From a Gastroenterology Outpatient Population. [PDF]

JGH Open
Fatakhova K, Khan MJ, Perera R, Perera S, Glazebnik B, Donnelly L, Patel P, Glazer E, Haggerty G, Ali H, Rajapakse R.   +10 more
europepmc   +1 more source

Effect of Broad‐Spectrum Antibiotic Prophylaxis on Post‐Pancreatoduodenectomy Infectious Complications: Nationwide Inpatient Database Study in Japan

Annals of Gastroenterological Surgery, EarlyView.
Using a nationwide Japanese inpatient database, we evaluated whether broad‐spectrum antibiotic prophylaxis improves postoperative outcomes after pancreatoduodenectomy compared with narrow‐spectrum antibiotics. In propensity score–weighted analyses of 45 099 patients, broad‐spectrum prophylaxis was associated with significantly lower rates of intra ...
Hiroki Kitagawa, Shotaro Aso, Yuki Hirano, Kenichiro Uemura, Keita Kouzu, Satoru Matsuda, Hiroki Matsui, Kiyohide Fushimi, Junichi Sasaki, Yuko Kitagawa, Hideo Yasunaga   +10 more
wiley   +1 more source

Antibiotic treatment for 1 day versus 4-7 days in patients with acute cholangitis after adequate endoscopic biliary drainage (COBRA): study protocol for a randomized controlled trial. [PDF]

Trials
Overdevest AG, Sieswerda E, Haal S, Bogaards JA, Baven-Pronk MAMC, Bogte A, Boparai KS, Ter Borg F, Brink MA, van Delft F, Dik VK, Fockens P, Gilissen LPL, Hadithi M, Hazen WL, van der Heide F, den Hollander WJ, Inderson A, de Jonge PJF, Kuiken SD, Munneke JM, Perk LE, Poen AC, Poley JW, Quispel R, Scheffer RCH, Schölvinck DW, van Soest EJ, Tan ACITL, Thijs WJ, Venneman NG, Verdonk RC, van de Vrie W, Vrolijk JM, van Wanrooij RLJ, Weijenborg PW, Dijkgraaf MGW, Prins JM, Voermans RP.   +38 more
europepmc   +1 more source

1-Minute Pearls/Pitfalls for the Clinician. [PDF]

J Brown Hosp Med
Gulla V, Luna Ceron E.
europepmc   +1 more source

Management Strategies for Disappearing Colorectal Liver Metastases After Systemic Chemotherapy: Long‐Term Outcomes and Preoperative Prediction of ‘True Complete Response’

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Determining whether to resect disappearing liver metastases (DLMs) after chemotherapy for colorectal liver metastases (CRLMs) remains challenging. Methods Patients who underwent hepatectomy after systemic chemotherapy for initially unresectable CRLMs were reviewed. True complete response (CR) was defined as either resected DLMs with
Taihei Soma, Ryo Ashida, Takeshi Kawakami, Katsuhisa Ohgi, Mihoko Yamada, Shimpei Otsuka, Yoshiyasu Kato, Kentaro Yamazaki, Katsuhiko Uesaka, Teiichi Sugiura   +9 more
wiley   +1 more source

Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. [PDF]

J Immunother Cancer
Sato Y, Kodama T, Maesaka K, Kai M, Murai K, Tahata Y, Saito Y, Nakabori T, Ohkawa K, Tanaka S, Sakamori R, Miyazaki M, Furuta K, Ishida H, Matsumoto K, Tawara S, Yakushijin T, Nozaki Y, Hosui A, Nishio A, Tatsumi N, Kakita N, Yoo C, Fukai M, Taketomi A, Hikita H, Tatsumi T, Takehara T.   +27 more
europepmc   +1 more source

Reappraisal of Real‐World Management of Acute Cholecystitis in Elderly Patients Based on the Adherence to Tokyo Guidelines 2018 (TG18): A Multicenter Study on Anzu HPB Surgical Meeting

Annals of Gastroenterological Surgery, EarlyView.
This multicenter retrospective study analyzes real‐world management of acute cholecystitis in patients aged ≥ 70 years across five institutions, focusing on adherence and intentional deviation from TG18 recommendations. By classifying treatment strategies as TG18‐accordant, more aggressive, or more conservative, we reappraise current practice patterns.
Yuta Kobayashi, Shojiro Hata, Ryo Oikawa, Tetsuya Nakazato, Hiroki Sakata, Hirokazu Yamaguchi, Yutaka Suzuki, Yoshihiro Sakamoto   +7 more
wiley   +1 more source

Early Prediction of Hepatic Decompensation in Cirrhosis Using Optimised XGBoost Models at the Initial Outpatient Hepatology Visit. [PDF]

Liver Int
Grubert Van Iderstine M, Perez S, Jackson GS, Szun T, Stephanson C, Weisshaar M, Minuk GY, Faisal N.   +7 more
europepmc   +1 more source

Survival Outcomes of Gemcitabine–Cisplatin–S‐1 Versus Gemcitabine–Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery

Annals of Gastroenterological Surgery, EarlyView.
In this multicenter retrospective study conducted by the Biliary Tract Club, we compared survival outcomes between gemcitabine–cisplatin–S‐1 (GCS) and gemcitabine–cisplatin (GC) in patients with unresectable biliary tract cancer, with a particular focus on conversion surgery. GCS was associated with longer overall and progression‐free survival compared
Hisashi Kosaka, Masahiko Kinoshita, Satoshi Yasuda, Satoru Kakizaki, Rie Sugimoto, Jun Sakata, Kiyonori Yamai, Takeshi Hatanaka, Yusuke Yamamoto, Toshifumi Sato, Toru Ishikawa, Takanori Morikawa, Jun Hanaoka, Haruki Mori, Hidenori Toyoda, Tsuyoshi Sanuki, Misaki Yokoi, Hiroyuki Shibata, Koji Fukuda, Kazuhito Kawata, Koji Amaya, Takashi Ito, Masaaki Hidaka, Atsushi Naganuma, Keishi Sugimachi, Satoshi Toshiyama, Makoto Yamasaki, Masaki Kaibori   +27 more
wiley   +1 more source

Editorial: Women in gastrointestinal and hepatic pharmacology 2022

Frontiers in Pharmacology
Eleonora Lai, Jessica Williams, Raquel Abalo, Raquel Abalo, Raquel Abalo, Raquel Abalo, Raquel Abalo, Daniela Gabbia   +7 more
doaj   +1 more source